Bipolar disorder trials recruiting in New York

All Bipolar disorder trials nationally

Cities in New York

Recruiting trials in New York

• A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
  NCT06508450 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 34 Years · Sex: All (male and female) · New York: The Bronx
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
  NCT07172516 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · New York: Brooklyn, Cedarhurst, Staten Island
• A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
  NCT06696755 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
  NCT04777357 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · New York: Buffalo
• A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
  NCT06929273 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Staten Island
• A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
  NCT07140913 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Staten Island
• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
  NCT06951698 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Staten Island
• An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
  NCT07288320 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Staten Island
• Exercise and Olanzapine-samidorphan
  NCT06740890 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
  NCT06372964 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · New York: New York
• Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
  NCT07494305 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Personalized Mobile Cognitive Behavioral Therapy Application
  NCT05699525 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 25 Years · Sex: All (male and female) · New York: New York
• Safety and Feasibility of DBS for Bipolar Depression
  NCT07745374 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 70 Years · Sex: All (male and female) · New York: New York
• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
  NCT06229210 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · New York: New York, Staten Island
• Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
  NCT07220460 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Brooklyn, Cedarhurst, New York
• Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
  NCT05303064 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · New York: New York
• Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
  NCT06373016 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · New York: Stony Brook
• Visual Perception in Schizophrenia
  NCT06911931 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Rochester